Litigation (Drug Pricing Matters) (Details) - Mar. 31, 2022	Total	state
Multi District Litigation [Member]
Loss Contingencies [Line Items]
Number of states	46	46
Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]
Loss Contingencies [Line Items]
Number of states	36
Anticompetitive Conduct with Generic Drugs [Member]
Loss Contingencies [Line Items]
Number of states	47
Amended Anticompetitive Conduct with Generic Drugs [Member]
Loss Contingencies [Line Items]
Number of states	42